The Potential and Current Progress of Internalizing Molecules in Targeted Drug Delivery - Intracellular Delivery: Fundamentals and Applications - page 121

Pangburn, T. O., Petersen, M. A., Waybrant, B., Adil, M. M. & Kokkoli, E. (2009) Peptide- and
aptamer-functionalized nanovectors for targeted delivery of therapeutics. J Biomech Eng ,
131, 074005.
Park, J. W., Hong, K., Kirpotin, D. B., Colbern, G., Shalaby, R., Baselga, J., Shao, Y., Nielsen, U. B.,
Marks, J. D., Moore, D., Papahadjopoulos, D. & Benz, C. C. (2002) Anti-HER2 immunolipo-
somes: enhanced efficacy attributable to targeted delivery. Clin Cancer Res , 8, 1172-81.
Park, K., Lee, S., Kang, E., Kim, K., Choi, K. & Kwon, I. C. (2009) New Generation of
Multifunctional Nanoparticles for Cancer Imaging and Therapy. Advanced functional materials
19, 1553-1566.
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R. & Langer, R. (2007) Nanocarriers
as an emerging platform for cancer therapy. Nat Nanotechnol , 2, 751-60.
Peer, D. & Margalit, R. (2004a) Loading mitomycin C inside long circulating hyaluronan targeted
nano-liposomes increases its antitumor activity in three mice tumor models. Int J Cancer ,
108, 780-9.
Peer, D. & Margalit, R. (2004b) Tumor-targeted hyaluronan nanoliposomes increase the antitumor
activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor models.
Neoplasia , 6, 343-53.
Peer, D., Park, E. J., Morishita, Y., Carman, C. V. & Shimaoka, M. (2008) Systemic leukocyte-directed
siRNA delivery revealing cyclin D1 as an anti-inflammatory target. Science , 319, 627-30.
Peipp, M., Kupers, H., Saul, D., Schlierf, B., Greil, J., Zunino, S. J., Gramatzki, M. & Fey, G. H.
(2002) A recombinant CD7-specific single-chain immunotoxin is a potent inducer of apoptosis
in acute leukemic T cells. Cancer Res , 62, 2848-55.
Posner, M. R., Hideshima, T., Cannon, T., Mukherjee, M., Mayer, K. H. & Byrn, R. A. (1991) An
IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells,
and neutralizes infection. J Immunol , 146, 4325-32.
Prevo, R., Banerji, S., Ferguson, D. J., Clasper, S. & Jackson, D. G. (2001) Mouse LYVE-1 is an
endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem , 276, 19420-30.
Qian, Z. M., Li, H., Sun, H. & Ho, K. (2002) Targeted drug delivery via the transferrin receptor-
mediated endocytosis pathway. Pharmacol Rev , 54, 561-87.
Rao, K. S., Ghorpade, A. & Labhasetwar, V. (2009) Targeting anti-HIV drugs to the CNS. Expert
Opin Drug Deliv , 6, 771-84.
Ruoslahti, E. (2003) The RGD story: a personal account. Matrix Biol , 22, 459-65.
Russ, V. & Wagner, E. (2007) Cell and tissue targeting of nucleic acids for cancer gene therapy.
Pharm Res , 24, 1047-57.
Sattentau, Q. J. & Moore, J. P. (1993) The role of CD4 in HIV binding and entry. Philos Trans R
Soc Lond B Biol Sci , 342, 59-66.
Scheinberg, D. A., Tanimoto, M., McKenzie, S., Strife, A., Old, L. J. & Clarkson, B. D. (1989)
Monoclonal antibody M195: a diagnostic marker for acute myelogenous leukemia. Leukemia ,
3, 440-5.
Schrama, D., Reisfeld, R. A. & Becker, J. C. (2006) Antibody targeted drugs as cancer therapeu-
tics. Nat Rev Drug Discov , 5, 147-59.
Senter, P. D. & Springer, C. J. (2001) Selective activation of anticancer prodrugs by monoclonal
antibody-enzyme conjugates. Adv Drug Deliv Rev , 53, 247-64.
Shangguan, D., Cao, Z. C., Li, Y. & Tan, W. (2007) Aptamers evolved from cultured cancer cells
reveal molecular differences of cancer cells in patient samples. Clin Chem , 53, 1153-5.
Shangguan, D., Li, Y., Tang, Z., Cao, Z. C., Chen, H. W., Mallikaratchy, P., Sefah, K., Yang, C. J.
& Tan, W. (2006) Aptamers evolved from live cells as effective molecular probes for cancer
study. Proc Natl Acad Sci U S A , 103, 11838-43.
Shapira, S., Lisiansky, V., Arber, N. & Kraus, S. (2010) Targeted immunotherapy for colorectal can-
cer: monoclonal antibodies and immunotoxins. Expert Opin Investig Drugs , 19 Suppl 1, S67-77.
Shieh, Y. A., Yang, S. J., Wei, M. F. & Shieh, M. J. (2010) Aptamer-based tumor-targeted drug
delivery for photodynamic therapy. ACS Nano , 4, 1433-42.
Simard, P. & Leroux, J. C. (2009) pH-sensitive immunoliposomes specific to the CD33 cell sur-
face antigen of leukemic cells. Int J Pharm , 381, 86-96.